DCF — HILLS & DALES GENERAL HOSPITAL
Enterprise Value: $-3.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.1M
Enterprise Value
$-2.0M
PV of Cash Flows
$-1.1M
PV of Terminal Value
$-1.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $42.4M | $0.7M | 2.0% | $-1.1M | $-1.0M |
| Year 2 | $43.7M | $1.2M | 3.0% | $-0.7M | $-0.6M |
| Year 3 | $45.0M | $1.7M | 4.0% | $-0.4M | $-0.3M |
| Year 4 | $46.4M | $2.0M | 4.0% | $-0.2M | $-0.1M |
| Year 5 | $47.8M | $2.1M | 4.0% | $-0.1M | $-0.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$41.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.012059586896602893
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5